Page 75 - MI-2-1
P. 75

Microbes & Immunity                                                     Copper and cuproptosis in immunity



               Biomaterials. 2025;313:122762.                     2016;8(10):1056-1070.
               doi: 10.1016/j.biomaterials.2024.122762            doi: 10.1039/C5MT00316D
            14.  Nandi SK, Chakraborty A, Panda AK, Biswas A. M. Leprae   24.  Monestier M, Pujol AM, Lamboux A, et al. A liver-targeting
               HSP18  suppresses  copper  (II)  mediated  ROS  generation:   Cu(i) chelator relocates Cu in hepatocytes and promotes Cu
               Effect of redox stress on its structure and function. Int J Biol   excretion in a murine model of Wilson’s disease. Metallomics.
               Macromol. 2020;146:648-660.                        2020;12(6):1000-1008.
               doi: 10.1016/j.ijbiomac.2019.12.215                doi: 10.1039/d0mt00069h
            15.  Saini V, Tyagi K, Kumari R, Venkatesh V. Atomically   25.  Al-Saleh E, Nandakumaran M, Al-Harmi J, Sadan  T,
               precise copper nanoclusters mediated fenton-like reaction   Al-Enezi H. Maternal-fetal status of copper, iron,
               for cancer chemodynamic therapy.  Chem Commun.     molybdenum, selenium, and zinc in obese pregnant women
               2024;60(86):12593-12596.                           in late gestation. Biol Trace Elem Res. 2006;113(2):113-123.
               doi: 10.1039/D4CC03338H                            doi: 10.1385/BTER:113:2:113
            16.  Wang  N,  Liu  Y,  Peng  D,  et al.  Copper-based  composites   26.  Gromadzka  G, Antos A,  Sorysz  Z,  Litwin  T.  Psychiatric
               nanoparticles improve triple-negative breast cancer treatment   symptoms in Wilson’s disease-consequence of ATP7B gene
               with induction of apoptosis-cuproptosis and immune   mutations or just coincidence?-Possible causal cascades and
               activation. Adv Healthc Mater. 2024;13(28):e2401646.  molecular pathways. Int J Mol Sci. 2024;25(22):12354.
               doi: 10.1002/adhm.202401646                        doi: 10.3390/ijms252212354
            17.  Zhu K, Shi J, Yang R, Zhou C, Liu Z. Evidence based on   27.  Patel AH, Ghattu M, Mazzaferro N, et al. Demographics and
               mendelian randomization: Causal relationship between   outcomes related to Wilson’s disease patients: A nationwide
               mitochondrial biological function and lung cancer and its   inpatient cohort study. Cureus. 2023;15(9):e44714.
               subtypes. Neoplasia. 2023;46:100950.               doi: 10.7759/cureus.44714
               doi: 10.1016/j.neo.2023.100950                  28.  Ortiz JF, Morillo Cox A, Tambo W,  et al. Neurological
            18.  Kettner L, Seitl I, Fischer L. Recent advances in the   manifestations of Wilson’s disease: Pathophysiology and
               application of microbial diamine oxidases and other   localization of each component. Cureus. 2020;12(11):e11509.
               histamine-oxidizing enzymes. World J Microbiol Biotechnol.      doi: 10.7759/cureus.11509
               2022;38(12):232.
                                                               29.  Mainardi V, Rando K, Valverde M, et al. Acute liver failure due
               doi: 10.1007/s11274-022-03421-2                    to Wilson disease: Eight years of the national liver transplant
            19.  Ufnalska I, Drew SC, Zhukov I,  et al. Intermediate   program in Uruguay. Ann Hepatol. 2019;18(1):187-192.
               Cu(II)-thiolate  species  in  the  reduction  of  Cu(II)GHK  by      doi: 10.5604/01.3001.0012.7911
               glutathione: A handy chelate for biological Cu(II) reduction.
               Inorg Chem. 2021;60(23):18048-18057.            30.  Kaler SG, DiStasio AT. ATP7A-Related copper transport
                                                                  disorders. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA,
               doi: 10.1021/acs.inorgchem.1c02669                 Wallace SE, Amemiya A, editors. GeneReviews  Seattle, WA:
                                                                                                    ®
            20.  Ogra Y, Suzuki KT. Targeting of tetrathiomolybdate on   University of Washington; 1993.
               the copper accumulating in the liver of LEC rats.  J  Inorg   31.  Fujisawa C, Kodama H, Sato Y,  et al. Early clinical signs
               Biochem. 1998;70(1):49-55.                         and  treatment  of  Menkes  disease.  Mol Genet Metab
               doi: 10.1016/s0162-0134(98)00012-9                 Rep. 2022;31:100849.

            21.  Xu W, Suo A, Aldai AJM,  et al. Hollow calcium/copper      doi: 10.1016/j.ymgmr.2022.100849
               bimetallic  amplifier  for  cuproptosis/paraptosis/apoptosis   32.  Guitet M, Campistol J, Medina M. Menkes disease: Experience
               cancer therapy via cascade reinforcement of endoplasmic   in copper salts therapy. Rev Neurol. 1999;29(2):127-130.
               reticulum stress and mitochondrial dysfunction.  ACS
               Nano. 2024;18(43):30053-30068.                  33.  Zhu J, Liao Y, Li X, Jia F, Ma X, Qu H. Brain and the whole-
                                                                  body bone imaging appearances in Menkes disease: A case
               doi: 10.1021/acsnano.4c11455                       report and literature review. BMC Pediatr. 2024;24(1):411.
            22.  Zhang J, Zhu M, Wang Q, Yang H. The combined use of      doi: 10.1186/s12887-024-04885-x
               copper sulfate and trichlorfon exerts stronger toxicity on the   34.  Martinez-Fierro ML, Cabral-Pacheco GA, Garza-Veloz I,
               liver of zebrafish. Int J Mol Sci. 2023;24(13):11203.
                                                                  et al. Whole-exome sequencing, proteome landscape, and
               doi: 10.3390/ijms241311203                         immune cell migration patterns in a clinical context of
                                                                  menkes disease. Genes (Basel). 2021;12(5):744.
            23.  Albarede F, Telouk P, Balter V, et al. Medical applications
               of  Cu,  Zn,  and  S  isotope  effects.  Metallomics.      doi: 10.3390/genes12050744


            Volume 2 Issue 1 (2025)                         67                               doi: 10.36922/mi.5657
   70   71   72   73   74   75   76   77   78   79   80